Is point-of-care (POC) glycated hemoglobin (A1c) testing the best choice for diabetes screening? The option is an attractive one; POC A1c testing provides the convenience of rapid results in a single ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

The new option will be covered by private insurance beginning in January 2027. A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...